Cintas (CTAS) traded lower Friday, down roughly 3% to around $169.62, as traders revisited uncertainty around its pending acquisition of UniFirst. The deal is already a key overhang for the stock because it introduces both regulatory (FTC/DOJ) risk and integration/financial risk, and the market often reprices those risks when new process milestones hit or when sentiment shifts toward defensives and away from higher-multiple names.

The Cintas–UniFirst transaction has progressed into formal U.S. antitrust review steps, with filings made to U.S. competition authorities for the roughly $5.5 billion merger. That development keeps attention on timing, the possibility of a second request, and whether any remedies could be required—factors that can pressure the acquirer’s shares even when the strategic rationale is intact. (mlex.com)

Cintas has been trading at a premium valuation versus many industrial and business-services peers, leaving the stock sensitive to “risk-off” positioning and any incremental uncertainty around execution. Separately, recent analyst actions have emphasized valuation and cyclical risk; Citi maintained a sell rating and cut its target to $160 on March 31, 2026, a reference point that can re-enter the narrative on down days. (insidermonkey.com)

Investors will be monitoring the regulatory calendar for signs of extended review (including potential follow-up requests) and any commentary around expected close timing. Deal-specific terms and antitrust process mechanics described in the merger registration materials will also stay in focus as the review proceeds, because they outline how the companies plan to manage approvals and potential delays. (stocktitan.net)